HOXA11 was significantly downregulated in cisplatin-resistant lung adenocarcinoma cell lines compared with parent cell lines, and in vitro experiments showed that overexpression of HOXA11 increased cisplatin sensitivity by inhibiting Akt/β-catenin signaling (34). Here, HOXA11 is linked to lung adenocarcinoma.